SynthesisJournal of cancer survivorship : research and practice2026
The lived experience of active surveillance for prostate cancer: a systematic review and meta-synthesis.
Synthesis in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Thinking, Feeling, Choosing: How Affect Is Reflected in Prostate Cancer Treatment Decision Making-A Qualitative Study.Psycho-oncology · 2026Article
- Exploring Lived Experiences of Men Diagnosed With Prostate Cancer in Oman: A Qualitative Study.Health expectations : an international journal of public participation in health care and health policy · 2026Article
- Developing and Assessing the Acceptability of an Information Booklet for Patients in Surveillance for Abdominal Aortic Aneurysms: An Intervention Development Study.Health expectations : an international journal of public participation in health care and health policy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeProstate cancer is one of the most prevalent cancers worldwide. Active surveillance is a widely accepted treatment option for some localised prostate cancers. However, concerns have been raised about the experiences of men on this treatment given that almost 40% will discontinue without clinical indications. The objective of this review was to identify the lived experience of men on active surveillance.
methodsA systematic review and meta-synthesis, according to PRISMA guidelines. Studies were included if they reported qualitative data exploring the experiences of men undertaking active surveillance. Thomas and Harden's approach was undertaken for data synthesis.
resultsFive databases were searched identifying 3226 articles, and 13 studies met the inclusion criteria. Two overarching analytical themes were identified: (i) men on active surveillance live with a lack of certainty; and (ii) re-establishing agency drives resilience and facilitates confidence in active surveillance. Lack of certainty on active surveillance is derived from men feeling a loss of control over their health and/or lives. This induces a stress response of ongoing worry and anxiety and loss of agency, further driving the stress cycle. Re-establishing agency alleviates the stress response, promotes resilience, and facilitates confidence in active surveillance.
conclusionsThe experience of active surveillance is underpinned by ongoing lack of certainty diminishing agency and driving cyclical stress. IMPLICATIONS FOR CANCER SURVIVORS: It is essential that health professionals better support men to establish and maintain confidence in active surveillance. Further research into men's perspectives of interventions and strategies that best facilitate agency and effectively support them is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.